Lung Cancers Completed Phase 3 Trials for Gemcitabine (DB00441)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00863512Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerTreatment
NCT00193362Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung CancerTreatment
NCT00079287Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00074204Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00005093Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung CancerTreatment
NCT00004199Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung CancerTreatment
NCT00003159Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung CancerTreatment
NCT00003589Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerTreatment